Adicet merges with resTorbio for CAR T-cell therapy pipeline funding
FierceBiotech - 30-Apr-2020The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year
Join the club for FREE to access the whole archive and other member benefits.
Capital market company
Orbimed Advisors is an investment company that was founded in 1989 with a vision to “invest across the spectrum of healthcare companies from venture capital start-ups to large multinational companies.”
Visit website: http://www.orbimed.com/
Details last updated 05-May-2020
The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year